Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: PCI Biotech AS
Woman and Man
Between 18 years
and 99 years
PCI Biotech AS
Update Il y a 4 ans
Étude PCIA202/10 : étude de phase 2 évaluant la tolérance et l’efficacité du PC-A11 associé à une application de lumière laser superficielle et interstitielle, chez des patients ayant un carcinome épidermoïde récidivant de la tête et du cou, pour lequel ni la chirurgie ni la radiothérapie ne peuvent être utilisées. [essai clos aux inclusions]
L’objectif de cette étude est d’évaluer la tolérance et l’efficacité de PC-A11 associé à une application de lumière laser superficielle et interstitielle chez des patients atteints de carcinomes épide...
Country
France
organs
Tête et cou
Specialty
Chimiothérapie
,
Autres (cryothérapie, radiofréquence, homéopathie,...)
Essai clos aux inclusions
More information
Woman and Man Max 99 years
PCI Biotech AS
Update Il y a 4 ans
A study to investigate the safety, tolerability and efficacy of PCI/Gemcitabine treatment followed by combination chemotherapy in patients with cholangiocarcinomas
Phase I Dose Escalation • To determine a tolerable dose and safety profile of Amphinex-induced PCI of gemcitabine followed by systemic gemcitabine/cisplatin chemotherapy in patients with advanced i...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
PCI Biotech AS
Update Il y a 4 ans
A study to investigate the efficacy and safety of the PC-A11 treatment in patients with head and neck cancers
The ‘run-in part’ primary objective: • To determine a safe light dose for PC-A11 with interstitial laser light application in patients with recurrent head and neck squamous cell carcinoma unsuitable ...
Country
None
organs
None
Specialty
None
Closed trial
More information